0.5389
price up icon6.73%   0.034
after-market After Hours: .52 -0.0189 -3.51%
loading

Ensysce Biosciences Inc Stock (ENSC) Forecast

The Ensysce Biosciences Inc (ENSC) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $298.26, representing a +55,246% increase from the current price of $0.5389. The highest analyst price target is $306.86, and the lowest is $289.66.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ENSC Price Target
Average 184.46 (+34,130% Upside)
loading

Is Ensysce Biosciences Inc (ENSC) A Buy Now?

Oscillators
Name Value Action
RSI(14) 47.37 Neutral
STOCH(9,6) 45.23 Neutral
STOCHRSI(14) 77.74 Neutral
MACD(12,26) -0.0649 Buy
ADX(14) 28.38 Buy
William %R -50.72 Neutral
CCI(14) 91.03 Neutral
Buy: 2 Sell: 0 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
0.4729
Buy
0.4995
Buy
MA20
0.459
Buy
0.5247
Buy
MA50
0.7329
Sell
0.7669
Sell
MA100
1.3102
Sell
1.1766
Sell
MA200
1.7509
Sell
2.1373
Sell
Buy: 4 Sell: 6 Neutral: 0
Summary: Sell
According to our latest analysis, ENSC could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 6 signaling Sell signals and 5 Neutral signals. This suggests that investors should exercise caution when entering new positions on ENSC, as the market is likely to remain volatile in the near term.
  1. RSI (Relative Strength Index): The RSI(14) value of 47.37 indicates that ENSC is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 45.23 indicates that ENSC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 77.74 indicates that ENSC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 28.38 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 91.03 indicates that ENSC is still overbought but not to an extreme extent.

Long-term ENSC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Ensysce Biosciences Inc financial reports and earnings history, Ensysce Biosciences Inc (ENSC) stock could reach $316.11 by 2030, $3,891.55 by 2040 and $5,433.93 by 2050. See the projected annual prices until 2050 of the Ensysce Biosciences Inc stock below:

  • Ensysce Biosciences Inc (ENSC) is expected to reach an average price of $1,791.18 in 2035, with a high prediction of $1,818.67 and a low estimate of $1,792.38. This indicates an $332.28K% rise from the last recorded price of $0.5389.
  • Ensysce Biosciences Inc (ENSC) stock is projected to chart a bullish course in 2040, with an average price target of $3,932.35, representing an $729.60K% surge from its current level. The forecast ranges from a conservative $26.44 to a sky-high $3,891.55.
  • Our analysts predict Ensysce Biosciences Inc (ENSC) to jump 416.58K% by 2045, soaring from $2,246.44 to an average price of $2,245.51, potentially reaching $2,345.78. While $2,246.44 is the low estimate, the potential upside is significant.
  • Ensysce Biosciences Inc (ENSC) stock is expected to climb by 2050, reaching an average of $5,398.93, a $1.00M% jump from its current level. However, a wide range of estimates exists, with high and low targets of $5,433.93 and $5,406.13, respectively, highlighting the market's uncertainty.

Ensysce Biosciences Inc Stock (ENSC) Year by Year Forecast

Ensysce Biosciences Inc Stock (ENSC) Price Forecast for 2026

The predicted value for Ensysce Biosciences Inc (ENSC) in 2026 is set at an average of $240.06. Estimates vary from a peak of $355.76 to a trough of $124.36, indicating an +44,447% surge from the present price of $0.5389.
Month Average Low High Change from today's price
April, 2026 $289.57 $289.66 $306.86 +53,633%
May, 2026 $271.42 $271.51 $280.96 +50,265%
June, 2026 $252.59 $252.60 $266.53 +46,772%
July, 2026 $228.63 $228.65 $247.71 +42,326%
August, 2026 $209.50 $209.61 $223.79 +38,776%
September, 2026 $185.77 $185.82 $204.68 +34,372%
October, 2026 $166.91 $167.25 $180.93 +30,872%
November, 2026 $148.19 $148.30 $161.71 +27,398%
December, 2026 $124.30 $124.36 $143.26 +22,966%

Ensysce Biosciences Inc Stock (ENSC) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Ensysce Biosciences Inc (ENSC) is $504.75, with a high forecast of $1,004.67 and a low forecast of $4.8401. This indicates an +93,564% increase from the last price of $0.5389.
Month Average Low High Change from today's price
January, 2027 $104.98 $105.03 $119.28 +19,381%
February, 2027 $85.30 $85.77 $100.08 +15,729%
March, 2027 $62.02 $62.07 $80.13 +11,409%
April, 2027 $42.95 $43.02 $57.17 +7,869%
May, 2027 $23.83 $23.83 $38.10 +4,321%
June, 2027 $785.98 $4.8401 $745.18 +145.75K%
July, 2027 $728.44 $798.04 $757.23 +135.07K%
August, 2027 $769.30 $711.42 $637.27 +142.65K%
September, 2027 $920.58 $812.52 $860.58 +170.73K%
October, 2027 $1,031.04 $911.01 $997.41 +191.22K%
November, 2027 $661.50 $699.90 $1,004.67 +122.65K%
December, 2027 $750.37 $411.92 $467.17 +139.14K%

Ensysce Biosciences Inc Stock (ENSC) Price Forecast for 2028

In 2028, Ensysce Biosciences Inc (ENSC) is projected to reach an average price of $893.24, with a high projection of $992.86 and a low estimate of $793.62. This indicates an +165.65K% rise from the last price of $0.5389.
Month Average Low High Change from today's price
January, 2028 $899.23 $901.60 $867.14 +166.76K%
February, 2028 $990.49 $990.49 $992.86 +183.70K%
March, 2028 $937.76 $944.96 $964.10 +173.91K%
April, 2028 $897.02 $921.02 $892.21 +166.35K%
May, 2028 $978.53 $951.71 $986.58 +181.48K%
June, 2028 $964.09 $975.94 $961.94 +178.80K%
July, 2028 $895.99 $904.01 $892.40 +166.16K%
August, 2028 $888.58 $889.82 $887.90 +164.79K%
September, 2028 $867.90 $864.93 $870.90 +160.95K%
October, 2028 $859.01 $861.41 $855.75 +159.30K%
November, 2028 $831.12 $832.20 $843.42 +154.13K%
December, 2028 $790.74 $793.62 $820.94 +146.63K%

Ensysce Biosciences Inc Stock (ENSC) Price Forecast for 2029

The 2029 price forecast for Ensysce Biosciences Inc Stock (ENSC) is $554.61 on average, with a high prediction of $783.22 and a low estimate of $326.00. This represents an +102.82K% increase from the previous price of $0.5389.
Month Average Low High Change from today's price
January, 2029 $768.61 $770.53 $783.22 +142.53K%
February, 2029 $730.87 $731.36 $757.53 +135.52K%
March, 2029 $693.91 $694.09 $720.60 +128.66K%
April, 2029 $655.81 $656.53 $684.06 +121.59K%
May, 2029 $610.68 $611.32 $644.10 +113.22K%
June, 2029 $573.18 $573.23 $599.12 +106.26K%
July, 2029 $535.62 $535.68 $563.60 +99,292%
August, 2029 $488.02 $488.06 $525.95 +90,458%
September, 2029 $449.69 $449.72 $478.39 +83,347%
October, 2029 $401.94 $401.98 $439.98 +74,486%
November, 2029 $363.93 $363.96 $392.31 +67,432%
December, 2029 $325.86 $326.00 $354.30 +60,368%

Ensysce Biosciences Inc Stock (ENSC) Price Forecast for 2030

Ensysce Biosciences Inc Stock (ENSC) is expected to reach an average price of $856.39 in 2030, with a high forecast of $1,702.53 and a low forecast of $10.24. This signifies an +158.81K% surge from the last price of $0.5389.
Month Average Low High Change from today's price
January, 2030 $278.28 $278.38 $316.11 +51,539%
February, 2030 $239.75 $239.97 $268.68 +44,390%
March, 2030 $201.41 $201.48 $229.98 +37,274%
April, 2030 $162.54 $162.74 $191.48 +30,062%
May, 2030 $115.30 $115.38 $153.01 +21,296%
June, 2030 $77.10 $77.12 $105.70 +14,206%
July, 2030 $29.39 $29.43 $67.49 +5,353%
August, 2030 $1,563.00 $10.24 $1,531.78 +289.93K%
September, 2030 $1,447.89 $1,474.05 $1,529.44 +268.57K%
October, 2030 $1,647.20 $1,527.15 $1,520.00 +305.56K%
November, 2030 $1,618.49 $1,642.42 $1,601.42 +300.23K%
December, 2030 $1,721.78 $1,625.71 $1,702.53 +319.40K%
$45.68
price down icon 3.69%
$53.83
price down icon 6.87%
$29.72
price up icon 0.68%
$101.95
price down icon 1.78%
$143.57
price down icon 4.21%
biotechnology ONC
$292.94
price down icon 2.03%
Cap:     |  Volume (24h):